Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer
- PMID: 34092438
- DOI: 10.1016/j.eururo.2021.05.027
Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer
Comment on
-
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469183 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
